MMI receives FDA approval to expand REMIND microsurgery study - 2026-07-30 - Regulatory - The supplement followed FDA review of 30-day safety data from the first patient cohort. REMIND evaluates Symani-enabled microsurgical techniques intended to re-establish deep-cervical lymphatic drainage in patients with Alzheimer's… - source: globenewswire.com